Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-7wlv9 Total loading time: 0.652 Render date: 2022-05-25T16:16:26.106Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Book contents

94 - Sumatriptan, Sumatriptan/Naproxen

Published online by Cambridge University Press:  05 October 2012

Howard S. Smith
Affiliation:
Academic Director of Pain Management, Albany Medical College
Marco Pappagallo
Affiliation:
Director, Pain Management and Medical Mentoring, New York Medical Home for Chronic Pain
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Essential Pain Pharmacology
The Prescriber's Guide
, pp. 439 - 441
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brandes, JLKudrow, DStark, SRSumatriptan-naproxen for acute treatment of migraine: a randomized trialJAMA 2007 297 1443Google Scholar
Ferrari, MDRoon, KILipton, RBGoadsby, PJOral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trialsLancet 2001 358 1668Google Scholar
Göbel, HHeinze, AStolze, HHeinze-Kuhn, KLindner, VOpen-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatmentCephalalgia 1999 19 676Google Scholar
Scholpp, JSchellenberg, RMoeckesch, BBanik, NEarly treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptanCephalalgia 2004 24 925Google Scholar
Wenzel, RGTepper, SKorab, WEFreitag, FSerotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?Ann Pharmacother 2008 42 1692Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×